FACTORS ASSOCIATED WITH DEVELOPMENT OF MENTAL ILLNESS IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING BIOLOGICAL AND TARGETED SYNTHETIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS: A POPULATION-BASED STUDY

被引:0
|
作者
Chen, H. H. [1 ,2 ]
Chao, W. C. [1 ,3 ]
机构
[1] Natl Chung Hsing Univ, Dept Postbaccalaureate Med, Taichung, Taiwan
[2] Taichung Vet Gen Hosp, Dept Internal Med, Taichung, Taiwan
[3] Taichung Vet Gen Hosp, Dept Crit Care Med, Taichung, Taiwan
关键词
Targeted synthetic drugs; bDMARD; Mental health;
D O I
10.1136/annrheumdis-2023-eular.1176
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AB0289
引用
收藏
页码:1326 / 1326
页数:1
相关论文
共 50 条
  • [41] Clinical and therapeutic management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: RADAR study
    Gomez-Centeno, Antonio
    Rubio-Romero, Esteban
    Gabriel Ovalles, Juan
    Manrique-Arija, Sara
    Marsal-Barril, Sara
    Amarelo-Ramos, Juan
    del Pino-Montes, Javier
    Munoz-Fernandez, Santiago
    Bustabad, Sagrario
    Barbazan-Alvarez, Ceferino
    RHEUMATOLOGY INTERNATIONAL, 2019, 39 (12) : 2015 - 2024
  • [42] Clinical and therapeutic management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: RADAR study
    Antonio Gomez-Centeno
    Esteban Rubio-Romero
    Juan Gabriel Ovalles
    Sara Manrique-Arija
    Sara Marsal-Barril
    Juan Amarelo-Ramos
    Javier del Pino-Montes
    Santiago Muñoz-Fernández
    Sagrario Bustabad
    Ceferino Barbazán-Álvarez
    Rheumatology International, 2019, 39 : 2015 - 2024
  • [43] The Risk of Cardiovascular Events Associated With Disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis
    Ozen, Gulsen
    Pedro, Sofia
    Michaud, Kaleb
    JOURNAL OF RHEUMATOLOGY, 2021, 48 (05) : 648 - 655
  • [44] POSTOPERATIVE COMPLICATIONS IN RHEUMATOID ARTHRITIS PATIENTS RECEIVING RITUXIMAB AND CONVENTIONAL DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (DMARDS)
    Pogozheva, E.
    Amirdzhanova, V.
    Makarov, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 882 - 882
  • [45] Biological Disease-Modifying Antirheumatic Drugs and Osteoporotic Fracture Risk in Patients with Rheumatoid Arthritis: A Danish Cohort Study
    Abtahi, Shahab
    Cordtz, Rene
    Dreyer, Lene
    Driessen, Johanna H. M.
    Boonen, Annelies
    Burden, Andrea M.
    AMERICAN JOURNAL OF MEDICINE, 2022, 135 (07): : 879 - +
  • [46] Is it possible to discontinue glucocorticoids in rheumatoid arthritis with the use of synthetic disease-modifying antirheumatic drugs?
    Iaremenko, O. B.
    Mykytenko, H. M.
    ZAPOROZHYE MEDICAL JOURNAL, 2023, 25 (04) : 309 - 315
  • [47] Safety of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis as used in clinical practice: results from the ARTIS programme
    Frisell, Thomas
    Bower, Hannah
    Morin, Matilda
    Baecklund, Eva
    Di Giuseppe, Daniela
    Delcoigne, Benedicte
    Feltelius, Nils
    Forsblad-d'Elia, Helena
    Lindqvist, Elisabet
    Lindstroem, Ulf
    Askling, Johan
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (05) : 601 - 610
  • [48] Comparative Risk of Nonvertebral Fractures Among Patients With Rheumatoid Arthritis Treated With Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drugs
    Pawar, Ajinkya
    Desai, Rishi J.
    He, Mengdong
    Bessette, Lily
    Kim, Seoyoung C.
    ACR OPEN RHEUMATOLOGY, 2021, 3 (08) : 531 - 539
  • [49] Budget Impact of Sequential Treatment with Biologics, Biosimilars, and Targeted Synthetic Disease-Modifying Antirheumatic Drugs in Thai Patients with Rheumatoid Arthritis
    Osiri, Manathip
    Dilokthornsakul, Piyameth
    Chokboonpium, Sasitorn
    Suthipinijtham, Pichaya
    Koolvisoot, Ajchara
    ADVANCES IN THERAPY, 2021, 38 (09) : 4885 - 4899
  • [50] Frailty and Risk of Serious Infections in Patients With Rheumatoid Arthritis Treated With Biologic or Targeted-Synthetic Disease-Modifying Antirheumatic Drugs
    Singh, Namrata
    Gold, Laura S.
    Lee, Jiha
    Wysham, Katherine D.
    Andrews, James S.
    Makris, Una E.
    England, Bryant R.
    George, Michael D.
    Baker, Joshua F.
    Jarvik, Jeffrey
    Heagerty, Patrick J.
    Singh, Siddharth
    ARTHRITIS CARE & RESEARCH, 2024, 76 (05) : 627 - 635